Werewolf Therapeutics Inc

NAS:HOWL (USA)  
$ 7.39 +0.76 (+11.46%) 10:08 PM EST
At Loss
P/B:
2.34
Market Cap:
$ 300.28M
Enterprise V:
$ 222.41M
Volume:
195.56K
Avg Vol (2M):
287.27K
Volume:
195.56K
At Loss
Avg Vol (2M):
287.27K

Business Description

Werewolf Therapeutics Inc
NAICS : 541714 SIC : 2834
ISIN : US95075A1079
Description
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 2.49
Equity-to-Asset 0.64
Debt-to-Equity 0.46
Debt-to-EBITDA -1.34
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.48
Distress
Grey
Safe
Beneish M-Score 1.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -19.9
3-Year EPS without NRI Growth Rate 2.2
3-Year FCF Growth Rate -11.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 79.03
9-Day RSI 73
14-Day RSI 70.38
6-1 Month Momentum % 51.94
12-1 Month Momentum % 28.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.64
Quick Ratio 9.64
Cash Ratio 9.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -51.9
Shareholder Yield % -12.85

Financials (Next Earnings Date:2024-03-22 Est.)

HOWL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HOWL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Werewolf Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 25.725
EPS (TTM) ($) -1.1
Beta 0
Volatility % 85.02
14-Day RSI 70.38
14-Day ATR ($) 0.550258
20-Day SMA ($) 6.12325
12-1 Month Momentum % 28.52
52-Week Range ($) 1.5735 - 7.39
Shares Outstanding (Mil) 40.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Werewolf Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Werewolf Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Werewolf Therapeutics Inc Frequently Asked Questions

What is Werewolf Therapeutics Inc(HOWL)'s stock price today?
The current price of HOWL is $7.39. The 52 week high of HOWL is $7.39 and 52 week low is $1.57.
When is next earnings date of Werewolf Therapeutics Inc(HOWL)?
The next earnings date of Werewolf Therapeutics Inc(HOWL) is 2024-03-22 Est..
Does Werewolf Therapeutics Inc(HOWL) pay dividends? If so, how much?
Werewolf Therapeutics Inc(HOWL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1